145 related articles for article (PubMed ID: 1673596)
1. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.
Unger P; Hoffman K; Pertsemlidis D; Thung S; Wolfe D; Kaneko M
Arch Pathol Lab Med; 1991 May; 115(5):484-7. PubMed ID: 1673596
[TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
3. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma.
Lamovec J; Frković-Grazio S; Bracko M
Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019
[TBL] [Abstract][Full Text] [Related]
4. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
5. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?
van der Harst E; Bruining HA; Jaap Bonjer H; van der Ham F; Dinjens WN; Lamberts SW; de Herder WW; Koper JW; Stijnen T; Proye C; Lecomte-Houcke M; Bosman FT; de Krijger RR
J Pathol; 2000 Jun; 191(2):175-80. PubMed ID: 10861578
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
Nagura S; Katoh R; Kawaoi A; Kobayashi M; Obara T; Omata K
Mod Pathol; 1999 Dec; 12(12):1107-11. PubMed ID: 10619262
[TBL] [Abstract][Full Text] [Related]
7. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues.
Lloyd RV; Blaivas M; Wilson BS
Arch Pathol Lab Med; 1985 Jul; 109(7):633-5. PubMed ID: 3839362
[TBL] [Abstract][Full Text] [Related]
8. [Causes of recurrence of patients with chromaffin tumors].
Bel'tsevich DG; Kuznetsov NS
Khirurgiia (Mosk); 2002; (8):19-23. PubMed ID: 12389495
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
[TBL] [Abstract][Full Text] [Related]
10. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent pheochromocytoma].
Sun Z; Wang Y; Li Z
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):59-60. PubMed ID: 11715546
[TBL] [Abstract][Full Text] [Related]
12. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
Białas M; Okoń K; Dyduch G; Ciesielska-Milian K; Buziak M; Hubalewska-Dydejczyk A; Sobrinho-Simoes M
Pol J Pathol; 2013 Jun; 64(2):129-35. PubMed ID: 23900871
[TBL] [Abstract][Full Text] [Related]
14. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
Jiang CX; Zeng Z; Wang T; Liu X; Liu R; Li Y
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):762-6. PubMed ID: 22336161
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas or paragangliomas.
Pang LC; Tsao KC
Arch Pathol Lab Med; 1993 Nov; 117(11):1142-7. PubMed ID: 8239937
[TBL] [Abstract][Full Text] [Related]
16. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
[TBL] [Abstract][Full Text] [Related]
17. [Role of immunohistochemical study of extracellular matrix components in the estimation of the malignant potential of adrenal pheochromocytomas].
Bezuglova TV; Poliakova GA; Kazantseva IA
Arkh Patol; 2008; 70(6):19-21. PubMed ID: 19227276
[TBL] [Abstract][Full Text] [Related]
18. Oncologic aspects of pheochromocytoma: the importance of follow-up.
Scott HW; Halter SA
Surgery; 1984 Dec; 96(6):1061-6. PubMed ID: 6505959
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
[TBL] [Abstract][Full Text] [Related]
20. Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells.
Kontogeorgos G; Scheithauer BW; Kovacs K; Horvath E; Melmed S
Endocr Pathol; 2002; 13(3):197-206. PubMed ID: 12446918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
